Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

Gregory J. del Zoppo(University of Washington), Shirley M. Otis(Scripps Research Institute), Lawrence Brass(Yale University), Justin A. Zivin(University of California, San Diego), Mark J. Alberts(Nanotherapeutics (United States)), Klaus Poeck(Universitätsklinikum Aachen), O. Busse(Johannes Wesling Klinikum Minden), Ralph G. Greenlee(The University of Texas Southwestern Medical Center), J.P. Mohr(The Ohio State University), Daryl R. Gress(Harvard University Press), Werner Hacke(Heidelberg University), José Biller(Loyola University Chicago), Samuel M. Wolpert(Tufts University), A. Ferbert(Klinikum Kassel), Edward Feldmann(Providence College), Michael S. Pessin(Beth Israel Deaconess Hospital), Carlos S. Kase(Boston Medical Center), Anthony J. Furlan(Society of Interventional Radiology), Lawrence R. Wechsler(Hospital of the University of Pennsylvania)
Annals of Neurology
July 1, 1992
10.1002/ana.410320113
Cited by 1,003

Related Papers

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2019|7.2k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2018|5.5k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k